Clinical Trial Update: Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab with or without ipilimumab or chemotherapy in patients with previously untreated stage I-IIIA non-small cell lung cancer; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7 | Phase 2 | Status: COMPLETED | Results posted: 2025-03-05